Adverse effects of growth hormone replacement therapy in children.

Abstract

Human growth hormone (hGH) replacement therapy has been widely available for clinical purposes for more than fifty years. Starting in 1958, hGH was obtained from cadaveric pituitaries, but in 1985 the association between hGH therapy and Creutzfeldt-Jakob disease was reported. In the same year, the use of recombinant hGH (rhGH) was approved. Side effects of rhGH replacement therapy in children and adolescents include rash and pain at injection site, transient fever, prepubertal gynecomastia, arthralgia, edema, benign intracranial hypertension, insulin resistance, progression of scoliosis, and slipped capital femoral epiphysis. Since GH stimulates cell multiplication, development of neoplasms is a concern. We will review the side effects reported in all rhGH indications.

• Authors: Flavio Moutinho Souza, Paulo Ferrez Collett-Solberg
• Journal: Arquivos brasileiros de endocrinologia e metabologia (Arq Bras Endocrinol Metabol) Vol. 55 Issue 8 Pg. 559-65 (Nov 2011) ISSN: 1677-9487 [Electronic] Brazil
• PMID: 22218437 (Publication Type: Journal Article, Review)

Chemical References

• Human Growth Hormone

Topics

• Adolescent
• Child
• Growth Disorders (drug therapy)
• Hormone Replacement Therapy (adverse effects)
• Human Growth Hormone (adverse effects)
• Humans